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Influenza vaccine is effective at preventing influenza in healthy young adults.[1] The strategy
to encourage influenza vaccination for health care workers is partly based on the simple notion
that this can reduce the risk of staff acquiring and transmitting influenza to vulnerable patients
and thereby reduce associated morbidity and mortality. A number of investigators have
attempted to demonstrate the impact of influenza vaccine in healthcare workers on patient
outcomes.[2–5] They have used the most robust methodology available to them for assessing
group interventions, namely the cluster randomized controlled trial. These trials have focused
on long-term care facilities (LTCF) for the elderly. Such facilities house frail elderly patients
for months or years in congregate settings. Outbreaks of respiratory tract infections in LTCF
are extremely common. For example a surveillance study in Toronto identified 46 outbreaks
across 5 homes in 3 years (more than three outbreaks per home per year with an average case
fatality rate of 8%).[6] Despite high levels of resident vaccination, low vaccine efficacy in the
elderly means that they remain vulnerable to influenza and its complications. Residents have
very high rates of mortality and hospitalization especially during periods of influenza circula-
tion. Even when residents have regular visitors, their main contact with the outside world is
via healthcare staff. Long-term care facilities, therefore, provide an opportunity to demonstrate
proof of the principle that healthcare worker influenza vaccination can prevent influenza and
associated morbidity and mortality in their patients. Cluster randomized trials of staff vaccina-
tion in these settings have consistently shown benefit to residents (2–5) and this evidence has
been used to support influenza vaccination of healthcare workers more generally. Since part of
the rationale for vaccinating healthcare workers is patient protection some employers have
chosen to make staff vaccination a condition of employment, which has led to legal challenge.
De Serres and his co-authors present a number of arguments based on their assessment of the
evidence as to why they think mandatory vaccination is not warranted.[7]
In our study [4] we aimed to test the hypothesis that a campaign promoting influenza vacci-
nation of staff would reduce influenza-related morbidity and mortality in elderly residents of
long-term care facilities. The study was based in a national chain of LTCF providing 24 hour
nursing care (i.e. the subset of LTCF catering for the most frail elderly). We hypothesized that
the effect of the vaccine would be confined to periods when influenza was circulating and
undertook the study over two years to minimize the risk of being unable to demonstrate an
effect in a year with low levels of influenza circulation. The study took place over two winter
seasons, the first of which had considerably higher levels of community influenza activity and
influenza related deaths than the second. Although the first year has been reported as a vaccine
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mismatch year, meta-analyses show that vaccine effectiveness in healthy adults is not usually
significantly lowered during mismatch years [1] [8], and a study of mismatched inactivated
influenza vaccine in Canadian adults during this year showed a 62% relative risk reduction in
laboratory confirmed influenza.[9] During the period of more intense influenza circulation we
found highly statistically significant reductions in residents’ influenza like illness (9 fewer
reports per 100 residents in intervention vs. control homes– 95% CI 3–14 p = 0.004), GP con-
sultations for influenza like illness (7 fewer consultations per 100 residents 95% CI 2–12
p = 0.002), hospitalisations with influenza like illness (2 fewer hospitalisations per 100 resi-
dents -95% confidence intervals 0–3 p = 0.009) and all cause mortality (5 fewer deaths per 100
residents in intervention compared to control homes– 95% CI 2–7, p = 0.002). Although the
findings were highly significant the confidence intervals indicate a wide range of uncertainty
about the scale of the benefit. We found no significant decreases in any of our outcomes during
periods when influenza was not circulating in the community or in the second year when
influenza rates were substantially lower than the first. In our discussion, based on our own
findings and those from other studies, we concluded that healthcare worker vaccination pro-
vides an important level of resident protection in long-term care facility settings. While we
claimed that the findings may be generalizable to other settings we did not intend to imply
that the extent of the benefit would be similar in other settings. Indeed we think the effect is
likely to be substantially greater in long-term care facilities for frail elderly residents than in
the acute care setting or in long term care facilities catering for less frail patients.
De Serres assessment is based on four main points. First, De Serres et al assert that the clus-
ter-randomized trials violate the principle of dilution whereby the greatest reductions should
be observed in the most specific outcomes (e.g. greater relative reductions would be expected
for laboratory confirmed influenza than for all cause mortality). Since the studies were not ade-
quately powered to assess which outcomes had the greatest reductions and the confidence
intervals for all outcomes overlap we do not agree that the studies individually or collectively
violate this principle. For example in our study the reduction in influenza like illness was
greater than the reduction in GP consultations for influenza like illness which was in turn
greater than the reduction in hospitalisations with influenza like illness. The point estimate of
the reductions in all cause mortality (5 fewer deaths per 100 residents) was greater than that
for hospitalisations related to influenza like illness (2 fewer hospitalisations per 100 residents).
According to De Serres et al this would violate the principal of dilution. However the confi-
dence intervals for these measures overlap considerably (2–7 and 0–3 respectively) indicating
that we do not know which measure had the greatest reduction.
Secondly De Serres et al highlight that a high proportion of averted deaths were not
labelled as deaths with influenza like illness. We do not think this makes our results less plau-
sible firstly because many deaths will have occurred in hospital but were reported by nursing
home staff so they will not have been able to assess whether they had influenza like illness at
the time of death. Secondly influenza may trigger a chain of events leading to death but at the
time of death such patients may no longer have an influenza like illness. Since our data were
collected as aggregate total event numbers for each outcome we cannot tell how many of
those who died had a recent influenza like illness. Thirdly the symptomatology of influenza
may be very vague in the frail elderly with multiple co-morbidities, especially as they
approach death. Finally, as discussed above, the statistical uncertainty around estimates of
effect mean that whilst we can be confident that there was a highly significant reduction in
all cause mortality we do not know whether this represents a greater reduction than that in
influenza like illness deaths. We therefore reject De Serres et al’s assertion that these are para-
doxical findings or that they should “reinforce concerns about the reliability and validity of
the study’s conclusions.”
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Thirdly, De Serres et al highlight that in some trials protective effects were also observed
outside the time period when national surveillance detected influenza activity. This was not
the case for our study. We found no effect of the intervention for any of our outcomes outside
the period of influenza circulation, strengthening the credibility of our results. However it
should be noted that influenza surveillance only picks up the tip of the iceberg of influenza
activity such that early community transmission may be missed.[10] Periods of circulation
identified through national level surveillance often do not coincide with periods of circulation
identified at local level.[11] Sporadic outbreaks of influenza have also been observed in LTCFs
outside normal periods of influenza circulation.[12] Consequently the fact that other studies
found some of the protective effects outside the period when national surveillance indicated
circulation of influenza does not mean their results are implausible.
Finally, De Serres et al’s main criticism is that if the numbers needed to vaccinate (NNV) to
prevent one death in our study were extrapolated to all LTCF staff in the US the number of
deaths averted would be considerably greater than the annual number of deaths estimated to be
due to influenza in the US. Also, if extrapolated to all hospital health care workers in the US the
predicted number of deaths averted would exceed the number of influenza deaths in the US dur-
ing the 1918 pandemic. Whilst we proposed that the concept of staff vaccination protecting
patients was generalizable to other settings we did not claim that the estimate of the NNV would
be equivalent in other settings, indeed we think it self evident that this would not be the case.
In making their extrapolations De Serres et al first appear to project the findings of our
study to the whole of the US Long Term Care Sector. Our study took place in LTCFs for the
elderly in homes that have 24 hour nursing care. As such they cater for the most vulnerable
elderly patients with high levels of co-morbidity who are too ill to live at home or in communal
establishments with less intense support. It is not appropriate to seek to generalize the NNV
derived in this setting to the broader LTCF sector where residents are likely to be substantially
less vulnerable to the effects of influenza and where they may have more contact with the out-
side world. It is also not appropriate to seek to generalize this NNV to the acute hospital setting
where length of stay is short, patients are on average younger and patients have contact with
many people other than health care workers. In addition, De Serres et al focus solely on results
derived from the point estimate when assessing the credibility of the NNV figure whilst ignor-
ing the 95% confidence intervals around this estimate (5.8–20.4), which indicate a high level of
uncertainty about the scale of the effect size. De Serres et al also make the assumption that the
NNV would not increase as vaccination rates increase (e.g. assuming that increasing staff vac-
cination from 50% to 100% would have the same impact as increasing vaccination rates from 0
to 50%). This is unlikely to be the case due to herd immunity effects. De Serres et al’s extrapola-
tions to infer the impact of complete staff vaccination to settings that differ considerably from
that of nursing homes for frail elderly should therefore not be used to undermine the validity
of our findings in the nursing home sector.
In England and Wales on the night of the 2011 census there were 389,102 individuals usu-
ally resident in long term medical and care establishments but only 123,137 were aged 65 years
or over and living in long-term care facilities with 24 hour nursing care (i.e. the population
covered in our trial). [13] In our study the staff:resident ratio was 1.27 suggesting there would
be 157,211 nursing home staff in England and Wales—or if extrapolated to the whole of the
United Kingdom, 176,933. Our study increased overall staff vaccination rates from 5% to 35%
(although 48% of full time staff were vaccinated). This would equate to 53,080 additional vacci-
nations nationally. Given our estimates of NNV this suggests that achieving equivalent staff
vaccination levels as those obtained in our study across similar homes in the UK in a year with
a similar level of influenza activity would avert 6473 deaths (95% CI 2602–9152). A recent
modelling exercise estimated that on average there are around 14,000 annual cardiorespiratory
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deaths in the UK attributable to influenza in those aged 65 years or older.[14] These deaths are
further concentrated in those aged over 75 and those with comorbidities. High annual varia-
tion in influenza activity means these estimates have very high standard deviations such that
plausible annual attributable mortality figures can be several times this level. We therefore do
not think that the range of estimates we give for NNV is implausible. We do not think that this
scale of benefit would be realistic outside the specific setting of Long Term Care Facilities for
the elderly with 24 hour nursing cover. The cluster-randomised trials of staff vaccination in
long term care facilities collectively provide strong evidence of the principle that staff vaccina-
tion can protect patients but further work would be needed to establish the potential scale of
the benefit in different settings.
De Serres et al attempt to “recalibrate” the NNV for the hospital sector. Using a wide range
of assumptions they estimate that 6000 to 32,000 hospital workers would need to be vaccinated
before a single patient death could potentially be averted. In assessing these estimates they use
measures of the numbers of influenza related deaths reported in surveillance studies that are
assumed to be hospital acquired and therefore potentially preventable by staff vaccination. It
should be noted that without very rigorous application of swabbing and PCR testing of all
those developing respiratory symptoms in hospital the number of hospital acquired cases and
consequently the number of associated deaths is likely to be underestimated, and the NNV to
be overestimated. In addition the numbers of potentially preventable deaths used were based
on surveys in hospitals that already had staff vaccination programmes achieving staff vaccine
uptake of 40–70%. The estimates therefore do not account for cases of influenza and associated
deaths that may already have been prevented through this level of vaccination.
Doubtless, the debate as to whether or not staff influenza vaccination should be a condition
of employment will continue. If avoiding patient death was the sole aim of staff vaccination a
reasonable economic case could be made for staff vaccination in hospital settings at the NNV
estimated by De Serres (influenza vaccine costs less than $2 per dose). When factoring in the
prevention of unnecessary illnesses in patients and staff, associated health service costs and the
avoidance of staff sickness absence, the economic case is still more compelling. Economic argu-
ments cannot, however, indicate a level of protection at which vaccination should be made a
condition of employment. Regardless of such enforcement measures health care workers need
to consider their professional duty to take reasonable actions to protect their patients from
infection. De Serres et al argue that more broadly protective practices, such as staying home or
masking when acutely ill could be alternative approaches to protection, but unlike staff vaccina-
tion the effectiveness of these measures has not been assessed. The fact that viral shedding pre-
cedes symptom onset by around 24–48 hours, that many people with laboratory-confirmed
influenza have mild symptoms that may be hard to distinguish from the common cold and that
many infections are asymptomatic would minimise the effectiveness of such measures.
[10,15,16] Avoiding influenza through vaccination is an important approach for healthcare
workers to take to avoid unnecessarily passing infection on to their vulnerable patients.
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